Health Care/Hospital
Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
SOLAIRIA-1 and SOLAIRIA-2 will evaluate GB-0895 in approximately 1,600 patients with severe asthma whose disease remains inadequately controlled on current therapies These are the first global Phase 3 studies of a long-acting anti-TSLP antibody, marking a pivotal step as GB-0895 advances the pro...
2025-12-01 19:00
938
Lee's Pharm Supports Disaster Relief Efforts for Wang Fuk Court in Tai Po
HONG KONG, Dec. 1, 2025 /PRNewswire/ -- Lee's Pharmaceutical Holdings Limited (" Lee's Pharm" or the "Group", stock code: 0950.HK) expresses its deep condolences to the victims of the serious fire at Wang Fuk Court inTai Po, which caused multiple casualties and left many residents homeless and in ...
2025-12-01 18:46
953
Asia PGI and partners unveil preview of PathGen: new AI-powered outbreak intelligence tool
Asia-led, "sovereign-by-design" platform built for secure, decentralised pathogen intelligence-sharing across borders aims to break data silos and provide faster "time to actionable insight" of outbreaks, from detection to control measures being in place. SINGAPORE, Dec. 1, 2025 /PRNewswire/ -- ...
2025-12-01 17:10
1108
CooperVision Opens Regional Service Centre in partnership with CEVA Logistics to Accelerate Asia Pacific Growth.
Driving faster delivery and broader portfolio access across the region. SINGAPORE, Dec. 1, 2025 /PRNewswire/ -- CooperVision Asia Pacific, in collaboration with CEVA Logistics, has opened a new Regional Service Centre in Singapore, marking a significant milestone in both companies' commitment to ...
2025-12-01 17:10
3780
Medit recognized as the top brand in a global brand perception study by an external insights agency
Global sentiment analysis of 3,800 discussions from Reddit's r/Dentistry community highlights strong user recognition in software usability, workflow flexibility, and overall value. SEOUL, South Korea, Dec. 1, 2025 /PRNewswire/ -- Medit, a leading digital dentistry company, has been ranked as th...
2025-12-01 16:00
956
Hedia appoints new CEO: Rasmus Kofoed to succeed Lars Christian Lund
COPENHAGEN, Denmark, Dec. 1, 2025 /PRNewswire/ -- Danish diabetes‑tech company Hedia is implementing a leadership change effective1 December 2025, when Rasmus Kofoed will take over as Chief Executive Officer (CEO). He succeeds Lars Christian Lund, who after approximately 2 years in the role has d...
2025-12-01 16:00
907
The Wisdom Derived from the Great Migration: Hakka Medicine - The Unique "Medical Epic" of the Hakka People
HONG KONG, Dec. 1, 2025 /PRNewswire/ -- From November 23rd to 25th, the 7th World Hakka Conference was held in Meizhou,Guangdong. With the theme "Gathering Global Hakka Businesspeople to Foster High-Quality Development," the conference adhered to the principles of "openness, innovation, cooperati...
2025-12-01 15:26
909
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
Securely connecting AI agents across multiple companies for rapid response to
changing circumstances
KAWASAKI, Japan, Dec. 1, 2025 /PRNewswire/ -- Fujitsu Limited today announced
2025-12-01 15:24
1098
Oxford Instruments launches Imaris 11: boosting research productivity with clear, workflow-driven image analysis
LONDON, Dec. 1, 2025 /PRNewswire/ -- Oxford Instruments announces the release of Imaris 11, the latest generation of its industry-leading 3D/4D microscopy image visualisation and analysis software. The new version introduces an intuitive Workflow system, enhanced batch processing, and advanced to...
2025-12-01 09:00
1182
MetaOptics Announces Strategic Share Placement to Accelerate Growth and Meet Rising Global Demand
SINGAPORE, Dec. 1, 2025 /PRNewswire/ -- MetaOptics Ltd (Catalist: 9MT) (" MetaOptics" or the "Company", and together with its subsidiaries, the "Group"), a leading-edge semiconductor optics company, announced that it is proposing to raiseS$4.85 million through a placement of 6,685,028 new ordinary...
2025-12-01 08:30
1892
The Science of Longevity: Inside Prof. Mike Chan's Vision for Living Stronger, Smarter, and Longer
BANGKOK, Dec. 1, 2025 /PRNewswire/ -- Malaysia had a rare moment of reflection
this year when former Prime Minister Tun Dr. Mahathir Mohamad turned 100. His
milestone sparked public conversations about aging, vitality, and what it truly
means to remain strong at any age.
2025-12-01 00:57
1610
The Bioregenerative Sports Revolution: How Prof. Mike Chan Is Changing Athlete Recovery -- From Sabah to the Super Bowl
KOTA KINABALU, Malaysia, Dec. 1, 2025 /PRNewswire/ -- Big changes often start
in small ways. For Sabah FC, a top Malaysian football club, it began with a
simple agreement — a partnership with European Wellness, a medical group best
known for anti-aging and precursor stem cell therapy.
2025-12-01 00:27
1659
Perlis Royalty Join Prof. Mike Chan in Strengthening Malaysia's Fight Against Autism
KUALA LUMPUR, Malaysia, Nov. 30, 2025 /PRNewswire/ -- Malaysia's drive to modernize autism care received strong support today when the Raja Muda of Perlis, Tuanku Syed Faizuddin Putra Jamalullail, and his consort, Tuanku Dr. Hajah Lailatul Shahreen Akashah Khalil, attended the International Congr...
2025-12-01 00:07
1564
Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development
- Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC37 oral tablets achieved average absolute oral bioavailability of 4.2%, approximately 9-, 30-, and 60-fold higher than semaglutide, tirzepatide, and retatrutide in the oral SNAC formulation, respectively, in head-to...
2025-11-30 18:15
1300
Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery
SHANGHAI, Nov. 30, 2025 /PRNewswire/ -- On the afternoon of November 26, a major Grade 5 fire spread across multiple residential buildings inWang Fuk Court inTai Po, Hong Kong, causing severe casualties and drawing widespread public concern. In response, onNovember 28, Qiming Venture Partners mad...
2025-11-30 07:17
1690
ANKH Pain Relief Health Group Donates HK$1 Million to the Hong Kong Red Cross To Support Disaster Relief Efforts
HONG KONG, Nov. 29, 2025 /PRNewswire/ -- In response to the devastating No. 5 alarm fire at Wang Fuk Court,Tai Po, ANKH Pain Relief Health Group has donated HK$1 million to the Hong Kong Red Cross to support their "Tai Po Fire Emergency Appeal". The major blaze at Wang Fuk Court has caused serio...
2025-11-29 08:00
2384
Angel Yeast's 8,500-Ton Specialty Yeast Facility and New Brewing Microbial Pilot Platform Come Online
YICHANG, China, Nov. 28, 2025 /PRNewswire/ -- Angel Yeast
2025-11-28 20:58
2022
Inaticabtagene Autoleucel (YORWIDATM) New Drug Application for Lymphoma Approved, China's innovative CAR-T Enters a New Era of Dual Indications
BEIJING, Nov. 28, 2025 /PRNewswire/ -- On November 28, 2025, Juventas Cell Therapy Co., Ltd. (hereinafter referred to as "Juventas") announced that its independently developed CAR-T cell therapy product, Inaticabtagene Autoleucel ( Ina-cel) (tradename: YORWIDATM), has received new drug marketing a...
2025-11-28 20:52
1074
K-Beauty & K-MediTech Expo Malaysia 2025 Concludes Successfully, Strengthening Korea-Malaysia Collaboration Across Beauty and Healthcare Sectors
PENANG, Malaysia, Nov. 28, 2025 /PRNewswire/ -- K-Beauty Expo Malaysia 2025 and K-MediTech Expo Malaysia 2025, hosted by Gyeonggi Province and organised by KINTEX, have successfully concluded at the Penang Waterfront Convention Centre (PWCC) after a dynamic three-day showcase of Korea's leading b...
2025-11-28 20:11
1382
Tianlong Strengthens Transfusion Safety with Innovative Blood Screening Solutions on World AIDS Day 2025
XI'AN, China, Nov. 28, 2025 /PRNewswire/ -- On World AIDS Day 2025, Tianlong reiterates its commitment to advancing global transfusion safety by presenting its fully integrated nucleic acid blood screening solution. Combining high automation with high-sensitivity NAT reagents, the solution enable...
2025-11-28 18:33
1160
Week's Top Stories
Most Reposted
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 278 media titles]
2025-12-26 12:55ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 273 media titles]
2025-12-30 20:12
CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 263 media titles]
2025-12-29 09:00
ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange
[Picked up by 259 media titles]
2025-12-29 14:27